AMT-253 in Patients With Selected Advanced Solid Tumours

Clinical trial NCT05906862 · RECRUITING

Trial details

NCT number: NCT05906862
Sponsor: Multitude Therapeutics (Australia) Pty Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-11-06
Primary completion: 2026-09-30
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.